Health ministry issues advisory against unregulated stem cell therapies, restricts autism treatment to approved clinical trials
The Union health ministry issued an advisory against unregulated stem cell therapies. Therapeutic use of stem cells for autism is restricted to approved clinical trials. This advisory reiterates the existing framework governing stem cell research and therapy. It aligns with a Supreme Court ruling restricting unproven stem cell treatments. States and union territories must ensure strict compliance with the applicable framework.
RSS News
Economic times
0 thoughts on “Health ministry issues advisory against unregulated stem cell therapies, restricts autism treatment to approved clinical trials”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- 'Historic Milestone': Amit Shah says India secures deportation of narco kingpin Navpreet Singh from Turkey
- Floods in 255 villages of 6 districts of Bihar: 15 rivers in UP above danger mark; Temperature crosses 40°C in Rajasthan
- Asian Games 2026 Day 15 Live Update: Kumkum is playing for gold, facing Korea.
- Shivya Nath's column: The boundaries between the village and the city should be erased beautifully
- When, where and how will you be able to watch the India-Pakistan final live? Know live streaming details
